Kelley A. Parato

3.3k total citations
17 papers, 2.0k citations indexed

About

Kelley A. Parato is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Kelley A. Parato has authored 17 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kelley A. Parato's work include Virus-based gene therapy research (15 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Cancer Research and Treatments (5 papers). Kelley A. Parato is often cited by papers focused on Virus-based gene therapy research (15 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Cancer Research and Treatments (5 papers). Kelley A. Parato collaborates with scholars based in Canada, United States and South Korea. Kelley A. Parato's co-authors include John C. Bell, Peter Forsyth, Donna L. Senger, David H. Kirn, Theresa Falls, Caroline J. Breitbach, Brian D. Lichty, Alan Melcher, Cliona M. Rooney and Jennifer M Paterson and has published in prestigious journals such as Nature reviews. Cancer, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kelley A. Parato

17 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelley A. Parato Canada 15 1.7k 1.2k 815 442 350 17 2.0k
Guy Ungerechts Germany 27 1.5k 0.9× 1.2k 1.0× 782 1.0× 410 0.9× 228 0.7× 62 2.3k
Phonphimon Wongthida United States 21 1.2k 0.7× 866 0.7× 710 0.9× 507 1.1× 162 0.5× 31 1.8k
Shane Knowles Canada 6 1.3k 0.7× 656 0.6× 662 0.8× 530 1.2× 136 0.4× 7 1.8k
Caroline J. Breitbach Canada 28 2.5k 1.4× 2.1k 1.8× 1.2k 1.5× 1.1k 2.4× 538 1.5× 51 3.5k
Elizabeth J. Ilett United Kingdom 24 1.2k 0.7× 1.2k 1.0× 541 0.7× 602 1.4× 307 0.9× 38 1.9k
Shaoheng Ni United States 23 1.7k 1.0× 905 0.8× 1.3k 1.6× 287 0.6× 284 0.8× 27 2.1k
Anthony Power Canada 9 1.1k 0.6× 485 0.4× 496 0.6× 339 0.8× 142 0.4× 11 1.4k
Elena A. Kashentseva United States 23 1.7k 1.0× 938 0.8× 1.5k 1.8× 239 0.5× 193 0.6× 53 2.3k
Konstantin Doronin United States 26 1.5k 0.9× 741 0.6× 1.2k 1.5× 221 0.5× 251 0.7× 40 1.9k
Jennifer M Paterson Canada 5 956 0.6× 521 0.4× 447 0.5× 334 0.8× 151 0.4× 6 1.2k

Countries citing papers authored by Kelley A. Parato

Since Specialization
Citations

This map shows the geographic impact of Kelley A. Parato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley A. Parato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley A. Parato more than expected).

Fields of papers citing papers by Kelley A. Parato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelley A. Parato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley A. Parato. The network helps show where Kelley A. Parato may publish in the future.

Co-authorship network of co-authors of Kelley A. Parato

This figure shows the co-authorship network connecting the top 25 collaborators of Kelley A. Parato. A scholar is included among the top collaborators of Kelley A. Parato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelley A. Parato. Kelley A. Parato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shen, Chun Fang, et al.. (2023). Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1. Biotechnology Journal. 19(1). e2300244–e2300244. 4 indexed citations
2.
Ananth, Abhirami A., Lee‐Hwa Tai, Almohanad A. Alkayyal, et al.. (2016). Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence. PLoS ONE. 11(5). e0155947–e0155947. 61 indexed citations
3.
Breitbach, Caroline J., Kelley A. Parato, James M. Burke, et al.. (2015). Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Current Opinion in Virology. 13. 49–54. 39 indexed citations
4.
Diallo, Jean‐Simon, Fabrice Le Bœuf, Chantal G. Lemay, et al.. (2013). Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia. Clinical Cancer Research. 19(14). 3832–3843. 25 indexed citations
5.
Parato, Kelley A., Caroline J. Breitbach, Fabrice Le Bœuf, et al.. (2011). The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers. Molecular Therapy. 20(4). 749–758. 224 indexed citations
6.
Melcher, Alan, Kelley A. Parato, Cliona M. Rooney, & John C. Bell. (2011). Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide. Molecular Therapy. 19(6). 1008–1016. 195 indexed citations
7.
Heo, Jeong, Caroline J. Breitbach, Anne Moon, et al.. (2011). Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy. Molecular Therapy. 19(6). 1170–1179. 117 indexed citations
8.
Breitbach, Caroline J., Theresa Falls, Usaf E. Aladl, et al.. (2011). Targeting Tumor Vasculature With an Oncolytic Virus. Molecular Therapy. 19(5). 886–894. 161 indexed citations
9.
Hwang, Tae-Ho, Anne Moon, James M. Burke, et al.. (2011). A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma. Molecular Therapy. 19(10). 1913–1922. 122 indexed citations
10.
Boucher, Jonathan, Kelley A. Parato, Aurelia Busca, et al.. (2010). Disparate Regulation of LPS-Induced MAPK Signaling and IL-12p40 Expression Between Different Myeloid Cell Types with and without HIV Infection. Viral Immunology. 23(1). 17–28. 2 indexed citations
11.
Lun, Xueqing, Jennifer A. Chan, Hongyuan Zhou, et al.. (2010). Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma. Molecular Therapy. 18(11). 1927–1936. 77 indexed citations
12.
Bœuf, Fabrice Le, Jean‐Simon Diallo, J. Andrea McCart, et al.. (2010). Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing. Molecular Therapy. 18(5). 888–895. 106 indexed citations
13.
Parato, Kelley A., Brian D. Lichty, & John C. Bell. (2009). Diplomatic immunity: turning a foe into an ally.. PubMed. 11(1). 13–21. 20 indexed citations
14.
Breitbach, Caroline J., Jennifer M Paterson, Chantal G. Lemay, et al.. (2007). Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow. Molecular Therapy. 15(9). 1686–1693. 230 indexed citations
15.
Senger, Donna L., Tommy Alain, Kelley A. Parato, et al.. (2006). Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas. JNCI Journal of the National Cancer Institute. 98(21). 1546–1557. 76 indexed citations
16.
Power, Anthony, Jiahu Wang, Theresa Falls, et al.. (2006). Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity. Molecular Therapy. 15(1). 123–130. 159 indexed citations
17.
Parato, Kelley A., Donna L. Senger, Peter Forsyth, & John C. Bell. (2005). Recent progress in the battle between oncolytic viruses and tumours. Nature reviews. Cancer. 5(12). 965–976. 425 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026